STOCKSCREENR
Log In

BBLG

NASDAQ

Bone Biologics Corporation

$1.24+0.02(+1.64%)Mkt Cap: $2.23M

Key Stats

Market Cap

$2.23M

P/E Ratio

-0.47

EPS

$-2.65

Dividend Yield

0.00%

52-Week Range

$1.11 — $6.75

Volume

13.64K

Avg Volume

313.98K

Beta

0.42

Valuation

P/E (TTM)

-0.47

Forward P/E

—

PEG Ratio

0.08

P/S (TTM)

0.00

P/B (TTM)

0.27

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.59%

ROA (TTM)

-0.54%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.00

Current Ratio

13.85

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.31%

EPS Growth (5Y)

+0.27%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-1.36

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$4.54

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

1.80M

Float

1.79M

Free Float %

99.56%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2021-10-13

Employees

2

CEO

Jeffrey Frelick

Index Membership

—

Website

https://www.bonebiologics.com

Bone Biologics Corporation (BBLG) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $2.23M, a P/E ratio of -0.47, BBLG is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BBLG against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NXL

Nexalin Technology, Inc.

$0.41

+0.57%

$7.63M

HSCS

HeartSciences Inc.

$2.65

-0.37%

$5.95M

AIDX

20/20 Biolabs, Inc. Common Stock

$2.16

-13.60%

$10.61M

NAOV

NanoVibronix, Inc.

$1.90

+1.06%

$1.51M

VVOS

Vivos Therapeutics, Inc.

$1.32

+1.54%

$7.77M

PAVM

PAVmed Inc.

$10.39

+3.38%

$5.58M

Frequently Asked Questions

What is Bone Biologics Corporation's P/E ratio?

Bone Biologics Corporation (BBLG) has a trailing twelve-month (TTM) P/E ratio of -0.47. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Bone Biologics Corporation pay a dividend?

No, Bone Biologics Corporation (BBLG) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Bone Biologics Corporation's market cap?

Bone Biologics Corporation (BBLG) has a market capitalization of $2.23 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.